Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Buisson

Showing results (61-70 of 166) with videos related to

Pageof 17
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 8, 2023
Histological healing induced by tofacitinib in ulcerative colitis: A multicentre studySophie Vieujean, David Laharie, Anthony Buisson, et al.
The American Journal of Gastroenterology|November 12, 2020
Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIXPauline Rivière, Geert D'Haens, Laurent Peyrin-Biroulet, et al.
Digestive Diseases and Sciences|February 23, 2018
Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative ColitisWing Yan Mak, Anthony Buisson, Michael J Andersen, et al.
Gut Microbes|September 29, 2022
Epigenetic master regulators HDAC1 and HDAC5 control pathobiont Enterobacteria colonization in ileal mucosa of Crohn's disease patientsMélissa Chervy, Adeline Sivignon, Flavie Dambrine, et al.
Alimentary Pharmacology & Therapeutics|December 28, 2020
Transmural healing and MRI healing are associated with lower risk of bowel damage progression than endoscopic mucosal healing in Crohn's diseasePierre Lafeuille, Constance Hordonneau, Jeanne Vignette, et al.
Journal of Crohn'S & Colitis|March 26, 2015
Monocyte-derived macrophages from Crohn's disease patients are impaired in the ability to control intracellular adherent-invasive Escherichia coli and exhibit disordered cytokine secretion profileEmilie Vazeille, Anthony Buisson, Marie-Agnès Bringer, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2022
Real-world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti-TNF agentAnthony Buisson, Maria Nachury, Thomas Guilmoteau, et al.
Cells|November 8, 2019
Macrophages Inability to Mediate Adherent-Invasive <i>E. coli</i> Replication is Linked to Autophagy in Crohn's Disease PatientsAnthony Buisson, Clara Douadi, Lemlih Ouchchane, et al.
Journal of Crohn'S & Colitis|January 13, 2022
Anti-TNF Agents Restrict Adherent-invasive Escherichia coli Replication Within Macrophages Through Modulation of Chitinase 3-like 1 in Patients with Crohn's DiseaseClara Douadi, Emilie Vazeille, Christophe Chambon, et al.
Scientific Reports|February 20, 2019
Metabolic adaptation of adherent-invasive Escherichia coli to exposure to bile saltsJulien Delmas, Lucie Gibold, Tiphanie Faïs, et al.
Pageof 17

Showing results (61-70 of 166) with videos related to

Sort By:
Pageof 17
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 8, 2023
Histological healing induced by tofacitinib in ulcerative colitis: A multicentre studySophie Vieujean, David Laharie, Anthony Buisson, et al.
The American Journal of Gastroenterology|November 12, 2020
Location but Not Severity of Endoscopic Lesions Influences Endoscopic Remission Rates in Crohn's Disease: A Post Hoc Analysis of TAILORIXPauline Rivière, Geert D'Haens, Laurent Peyrin-Biroulet, et al.
Digestive Diseases and Sciences|February 23, 2018
Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative ColitisWing Yan Mak, Anthony Buisson, Michael J Andersen, et al.
Gut Microbes|September 29, 2022
Epigenetic master regulators HDAC1 and HDAC5 control pathobiont Enterobacteria colonization in ileal mucosa of Crohn's disease patientsMélissa Chervy, Adeline Sivignon, Flavie Dambrine, et al.
Alimentary Pharmacology & Therapeutics|December 28, 2020
Transmural healing and MRI healing are associated with lower risk of bowel damage progression than endoscopic mucosal healing in Crohn's diseasePierre Lafeuille, Constance Hordonneau, Jeanne Vignette, et al.
Journal of Crohn'S & Colitis|March 26, 2015
Monocyte-derived macrophages from Crohn's disease patients are impaired in the ability to control intracellular adherent-invasive Escherichia coli and exhibit disordered cytokine secretion profileEmilie Vazeille, Anthony Buisson, Marie-Agnès Bringer, et al.
Alimentary Pharmacology & Therapeutics|November 19, 2022
Real-world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti-TNF agentAnthony Buisson, Maria Nachury, Thomas Guilmoteau, et al.
Cells|November 8, 2019
Macrophages Inability to Mediate Adherent-Invasive <i>E. coli</i> Replication is Linked to Autophagy in Crohn's Disease PatientsAnthony Buisson, Clara Douadi, Lemlih Ouchchane, et al.
Journal of Crohn'S & Colitis|January 13, 2022
Anti-TNF Agents Restrict Adherent-invasive Escherichia coli Replication Within Macrophages Through Modulation of Chitinase 3-like 1 in Patients with Crohn's DiseaseClara Douadi, Emilie Vazeille, Christophe Chambon, et al.
Scientific Reports|February 20, 2019
Metabolic adaptation of adherent-invasive Escherichia coli to exposure to bile saltsJulien Delmas, Lucie Gibold, Tiphanie Faïs, et al.
Pageof 17